China Pharma Holdings, Inc.(NYSE Amex Equities : CPHI)
CPHI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Generic
|TEVA||Teva Pharmaceutical Industries Ltd.||0.50%||10.12||2.0%||$80.88m|
|RDY||Dr. Reddy's Laboratories Ltd.||-1.25%||63.04||2.0%||$8.02m|
|JAGX||Jaguar Health, Inc.||0.00%||1.98||2.6%||$2.52m|
|TARO||Taro Pharmaceutical Industries Ltd.||0.42%||62.70||6.6%||$0.79m|
|ABEO||Abeona Therapeutics, Inc.||0.11%||0.90||3.7%||$0.66m|
|COCP||Cocrystal Pharma, Inc.||-1.69%||0.93||0.0%||$0.52m|
|CPHI||China Pharma Holdings, Inc.||1.89%||0.57||0.1%||$0.15m|
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The firmâ€™s product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Others, Comprehensive Healthcare and Protective Products. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.